| LIPID_ID | FA0163 |
| CHEM_NA | 14-HYDROPEROXY-4,7,10,12,16,19-DOCOSAHEXAE |
| NOIC ACID |
| COMMON_NA |
| MOL_FORMULA | C22H32O4 |
| MOL_WT | 360 |
| ABBREVIATION | 22:6(ω3,6,10,12,15,18)(14-OOH) |
| MELT_PT |
| BOIL_PT |
| OPT_ROT |
| REFRA_IND |
| DENSITY |
| SOLUBILITY |
| UV_SPEC | UV(130): CONJUGATED DIENE:λmax=237nm |
| UV(ME-ESTER;AFTER REDUCTION)(129): |
| CONJUGATED DIENE:λmax=236nm |
| IR_SPEC |
| NMR_SPEC |
| MS_SPEC | GC-EI-MS(ME-ESTER;AFTER REDUCTION AND |
| TMS)(129/130/146) GC-EI-MS(ME-ESTER;AFTER |
| REDUCTION,HYDROGENATION AND TMS)(129/130) |
| GC-CI-MS(ME-ESTER;AFTER REDUCTION,TMS |
| OR REDUCTION,HYDROGENATION,TMS)(130) |
| NOTE_SPEC |
| SOURCE | ﾄﾞｺｻﾍｷｻｴﾝの自動酸化(129) |
| ﾄﾞｺｻﾍｷｻｴﾝ酸からｱﾗｷﾄﾞﾝの12ｰﾘﾎﾟｷｼｹﾞﾅｰｾﾞの作用に |
| BIOL_ACTIV | ｱﾗｷﾄﾞﾝの12ｰLIPOXYGENASEの作用で生体中に生成し |
| たﾄﾞｺｻﾍｷｻｴﾝ酸の14ｰﾋﾄﾞﾛﾍﾟﾙｵｷｼﾄﾞは，さらにﾋﾄﾞﾛｷｼ |
| 酸等へと代謝されるが，それらの生理活性については |
| 不明な点が 多い(133/144) |
| NOTE |
| 1998年8月24日 | 163 / 513 ページ |